Recent progress in biological therapies for psoriasis has revealed the fundamental roles of tumour necrosis factor‐α (TNF‐α), interleukin (IL)‐23p19 and IL‐17A axis in pathogenesis. This evidence concerns the gene IL17A and psoriasis.